|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
Press
Release titled “PetLife Management Comments on Recent Market Activity” as released on May 28, 2017
|
|
|
|
|
|
99.2
|
|
Press
Release titled “PetLife Files for Patent for the Treatment of Cancer for Pets” as released on May 30, 2017
|
|
|
|
|
|
99.3
|
|
Press
Release titled “PetLife Explores New Scorpion Venom-Based Therapies for Growing Product Line” as released on May
26, 2017
|
|
|
|
|
|
99.4
|
|
Press
Release titled “PetLife Closes Acquisition of Assets for Dr. Geoff’s Real Food for Pets” as released on
May 23, 2017
|
|
|
|
|
|
99.5
|
|
Press
Release titled “PetLife Pharmaceuticals Engages Carter, Terry & Company for Financing of FDA Application”
as released on May 16, 2017
|
|
|
|
|
|
99.6
|
|
Press
Release titled “PetLife Finalizes Negotiations for Dr. Geoff’s Real Food for Pets” as released on April
18, 2017
|
|
|
|
|
|
99.7
|
|
Press
Release titled “PetLife: Holistic Pet Health is Next Big Trend in Veterinary Medicine” as released on April 12,
2017
|
|
|
|
|
|
99.8
|
|
Press
Release titled “PetLife: Millennial Pet Owners Leading Charge in Rapid Growth of Holistic Pet Care” as released
on March 24, 2017
|
|
|
|
|
|
99.9
|
|
Press
Release titled “PetLife Supersedes Expectations for the Acquisition of Dr. Geoff’s Real Food for Pets” as
released on March 21, 2017
|
|
|
|
|
|
99.10
|
|
Press
Release titled “PetLife Pharmaceuticals Provides an Eye-Opening View on a Recession Resistive Industry” as released
on March 7, 2017
|
|
|
|
|
|
99.11
|
|
Press
Release titled “PetLife Pharmaceuticals Signs Letter of Intent to Acquire Healthy Life Pets Brand” as released
on February 28, 2017
|
|
|
|
|
|
99.12
|
|
Press
Release titled “PetLife Pharmaceutical Taps National Public Relations Firm to Help Bring to Market Cancer Treatment
Originally Developed by Cuba” as released on February 21, 2017
|
|
|
|
|
|
99.13
|
|
Press
Release titled “World Renowned Veterinary Nutritionist Dr. R. Geoffrey Broderick Continues Groundbreaking Efforts to
Help Animals by Joining PetLife Pharmaceuticals, Inc. as the Chairman of Product Development and Advisory Board” as
released on February 9, 2017
|
|
|
|
|
|
99.14
|
|
Press
Release titled “PetLife Pharmaceuticals Announces Son of World Famous Veterinarian & Pet Industry Innovator, Geoffrey
Broderick, to Join the Company as the New President” as released on February 3, 2017
|
|
|
|
|
|
99.15
|
|
Press
Release titled “PetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for
Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels”
as released on January 10, 2017
|
|
|
|
|
|
99.16
|
|
Press
Release titled “Correction: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics
to Discuss Expansion of its Core Product Line” as released on December 7, 2016
|
|
|
|
|
|
99.17
|
|
Press
Release titled “PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss
Expansion of its Core Product Line” as released on December 7, 2016
|
|
|
|
|
|
99.18
|
|
Press
Release titled “PetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy”
While Preparing for FDA Submission” as released on December 6, 2016
|
|
|
|
|
|
99.19
|
|
Press
Release titled “PetLife Pharmaceuticals Updates Shareholders on the Company Progress with Vitalzul™ Studies and
Additional Product Offerings” as released on December 1, 2016
|
|
|
|
|
|
99.20
|
|
Press
Release titled “PetLife Pharmaceuticals Notes Recent Cuban Research Providing Profound Evidence of Caribbean Blue Scorpion
Venom’s Ability to Eradicate Cancer Cells as Continued Support for PetLife’s pre-INAD Studies of Vitalzul™”
as released on November 15, 2016
|
|
|
|
|
|
99.21
|
|
Press
Release titled “PetLife Pharmaceuticals and Lumleian, LLC Announce Partnership to Advance Development and Commercialization
of Promising Veterinary Health Pipeline” as released on October 27, 2016
|
|
|
|
|
|
99.22
|
|
Press
Release titled “PetLife Pharmaceuticals Announces the Addition of a Seasoned Marketing Specialist and Investor, Mrs.
Vyvyan Campbell, to the Board of Directors” as released on October 24, 2016
|
|
|
|
|
|
99.23
|
|
Press
Release titled “PetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific
Officer with plans to expand its Current Portfolio of Veterinarian Drugs and Nutraceuticals” as released on October
20, 2016
|
|
|
|
|
|
99.24
|
|
Press
Release titled “PetLife Pharmaceuticals is Pleased to Announce the Completion of the New Company Website” as released
on October 17, 2016
|
|
|
|
|
|
99.25
|
|
Press
Release titled “PetLife Pharmaceuticals Expands Cell Line Study with InnoVision in Preparation for FDA/CVM Registration
Submission” as released on October 13, 2016
|
|
|
|
|
|
99.26
|
|
Press
Release titled “PetLife Pharmaceuticals is Pleased to Showcase its New “Vitalzul™ Information Video”
along with a Corporate Update as released on October 10, 2016
|
|
|
|
|
|
99.27
|
|
Press
Release titled “PetLife Pharmaceuticals Announces pre-INAD (Investigational New Animal Drug) Cell Lines Study of Vitalzul™
has Begun” as released on September 7, 2016
|
|
|
|
|
|
99.28
|
|
Press
Release titled “PetLife Pharmaceuticals Sees Vitalzul™ as a Major Component in the Treatment of Cancer in Pets;
Releases Vitalzul™ Information and Testimonial Video” as released September 1, 2016
|
|
|
|
|
|
99.29
|
|
Press
Release titled “PetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA Submission”
as released on August 25, 2016
|